GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Chipscreen Biosciences Co Ltd (SHSE:688321) » Definitions » Scaled Net Operating Assets

Shenzhen Chipscreen Biosciences Co (SHSE:688321) Scaled Net Operating Assets : 0.76 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shenzhen Chipscreen Biosciences Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shenzhen Chipscreen Biosciences Co's operating assets for the quarter that ended in Mar. 2025 was ¥2,809.3 Mil. Shenzhen Chipscreen Biosciences Co's operating liabilities for the quarter that ended in Mar. 2025 was ¥338.7 Mil. Shenzhen Chipscreen Biosciences Co's Total Assets for the quarter that ended in Dec. 2024 was ¥3,250.9 Mil. Therefore, Shenzhen Chipscreen Biosciences Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2025 was 0.76.


Shenzhen Chipscreen Biosciences Co Scaled Net Operating Assets Historical Data

The historical data trend for Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Chipscreen Biosciences Co Scaled Net Operating Assets Chart

Shenzhen Chipscreen Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.58 0.69 0.84 0.76 0.76

Shenzhen Chipscreen Biosciences Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.71 0.74 0.73 0.76

Competitive Comparison of Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets falls into.


;
;

Shenzhen Chipscreen Biosciences Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(2781.54-334.587)/3203.249
=0.76

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3250.899 - 469.359
=2781.54

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1669.8 - 1096.17 - 239.043
=334.587

Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2025 )
=(Operating Assets (Q: Mar. 2025 )-Operating Liabilities (Q: Mar. 2025 ))/Total Assets (Q: Dec. 2024 )
=(2809.259-338.738)/3250.899
=0.76

where

Operating Assets(Q: Mar. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3311.703 - 502.444
=2809.259

Operating Liabilities(Q: Mar. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1749.841 - 1146.022 - 265.081
=338.738

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Chipscreen Biosciences Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shenzhen Chipscreen Biosciences Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Chipscreen Biosciences Co Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.
Executives
Shan Song Core technical personnel
Xie Zheng Sheng Supervisors
She Liang Ji senior management
Hai Ou Directors, senior managers
Pan De Si Senior management, core technical personnel
Zhang Li Bin senior management
Li Jian Xun Director
Li Zhi Bin senior management
Ning Zhi Qiang senior management
Zhao Shu Mei Director
Shen Jian Hua Supervisors

Shenzhen Chipscreen Biosciences Co Headlines

No Headlines